Healthcare technology provider Induction Healthcare has collaborated with NHS Trusts in South West London to assist with long-term outpatient care change.
The South West London Integrated Care System (ICS) will use Induction Zesty to assist their outpatient transformation initiative, according to Induction, a ‘leading virtual care platform driving the digital transformation of healthcare systems’ globally.
The collaboration comes at a time when the NHS secondary caregivers in England are focusing and spending heavily on digital transformation, with Induction Zesty reportedly set to benefit Trusts in South West London.
Induction Zesty has been advertised as a hospital’s ‘digital front door’, with an easy setup that allows users to manage their appointments, communications, and virtual consultations from the comfort of their smartphone.
Patients can now have a cohesive perspective of their care journey, spanning various caregivers, on a single digital platform.
The combined contracts, which cover 4 of SW London’s NHS Trusts, have periods between 2 to 9 years and will generate a total revenue of roughly £3.6m with an ARR of around £650,000 from FY23 onwards. As installation work is finished and the sites go operational, the firm expects to generate roughly £450K in revenue in FY23 from these deals.
The contracts were partly influenced by a strategic partnership between Cerner and Induction. The partnership developed a combined solution that was made available as part of a value-added reseller agreement to NHS Trusts, which were already Cerner clients as an extension of their current Cerner EPR contracts.
Induction obtained remote video consultations platform Attend Anywhere in South West London in June 2021. The ability to combine the features of both platforms will reportedly improve patient engagement and support the company’s growth plan for FY23 and beyond.
“This is an exciting first step and strong proof point in our strategy to support regional digital transformation via newly forming Integrated Care Systems,” stated, Induction CEO, James Balmain.
“We have a strong pipeline of further Cerner customers who are keen to purchase the joint Induction/Cerner patient portal. Equally encouraging is the positive reaction we’ve seen from customers around the integration of Attend Anywhere into our Induction Zesty product.”
Induction Healthcare shares increased nearly 4% to 42p following the announcement of collaborating with 4 NHS Trusts.